Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
12.5M
-
Shares change
-
-98.2K
-
Total reported value, excl. options
-
$25.4M
-
Value change
-
-$258K
-
Number of buys
-
3
-
Number of sells
-
-9
-
Price
-
$2.04
Significant Holders of Equillium, Inc. - COM (EQ) as of Q2 2022
26 filings reported holding EQ - Equillium, Inc. - COM as of Q2 2022.
Equillium, Inc. - COM (EQ) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.5M shares
.
Largest 10 shareholders include Decheng Capital Management III (Cayman), LLC (4.45M shares), VICTORY CAPITAL MANAGEMENT INC (3.58M shares), FRANKLIN RESOURCES INC (895K shares), VANGUARD GROUP INC (845K shares), Samsara BioCapital, LLC (616K shares), TANG CAPITAL MANAGEMENT LLC (600K shares), Cota Capital Management, LLC (562K shares), DEUTSCHE BANK AG\ (356K shares), GEODE CAPITAL MANAGEMENT, LLC (159K shares), and DCF Advisers, LLC (114K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.